Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines

Toxicology and Applied Pharmacology

Volumn 169, Issue 2, 2000, Pages 132-141

  Chen, Rong Jane ^a   Lee, Wen Sen ^a   Liang, Yu Chih ^b   Lin, Jen Kun ^b   Wang, Ying Jan ^c   Lin, Chien Huang ^a   Hsieh, Jui Ying ^a   Chaing, Chiu Chin ^a   Ho, Yuan Soon ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cip1; G0; G1 arrest; Ketoconazole; p21; p53

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; KETOCONAZOLE; PROTEIN KIP1; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0034386967     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.9062     Document Type: Article

References (64)

1. Functional analysis of a p21/WAF1/CIP1/SID1 mutant (arg94-Trp) identified in a human breast carcinoma
2. P53 in signaling checkpoint arrest and apoptosis
3. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo
4. Potentiation of interleukin 1α mediated antitumor effects by ketoconazole
5. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
6. P21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells
7. Inhibitors of cytochrome p450-dependent arachidonic acid metabolism
8. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle
9. Growth and hepatospecific gene expression of human hepatoma ceils a defined medium
10. cAMP-dependent positive control of cyclin A2 expression during G1/S transition in primary hepatocytes
11. Treatment of systemic mycosis with ketoconazole: Emphasis on toxicity and clinical response in 52 patients
12. WAF1, a potential mediator of p53 tumor suppression
13. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
14. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications
15. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
16. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
17. P21-negative regulator of the cell cycle
18. Mutations in the p53 tumor suppressor gene: Clue to cancer etiology and molecular pathogenesis
19. Cell cycle regulation of cdk2 activity by phosphorylation of the thr160 and tyr 15
20. Tinea capititis: An overview with emphasis on management
21. Biochemical properties and biological effects of p53
22. Endocrine effects of high-dose ketoconazole therapy in advanced prostatitic cancer
23. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)
24. Induction of p53 and p21/Cip1 expression by nitric oxide and their association with apoptosis in human cancer cells
25. Ketoconazole-induced apoptosis through p53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines
26. Identification of a developmental timer regulating the stability of embryonic cyclin A and a new somatic A-type cyclin at gastrulation
27. The human papilloma virus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21/Cip1-mediated inhibition of cdk2
28. Levels of p53 protein increase with maturation in human hematopoietic cells
29. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase
30. Identification of p53 as a sequence-specific DNA-binding protein
31. Human hepatocellular carcinoma cell lines secret the major plasma proteins and hepatitis B surface antigen
32. P53 Puzzle and paradigm
33. Effects of ketoconazole on cholesterol synthesis
34. P53, the cellular gatekeeper for growth and division
35. Cyclin A1 is required for meiosis in the male mouse
36. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
37. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome p450-dependent enzymes
38. Ketoconazole binds to glucocorticoid receptors and inhibits glucocorticoid antagonist activity in cultured cells
39. Evidence for a p23 caspase-cleaved form of p27/Kip1 involved in G1 growth arrest
40. Ketoconazole and liarozole in the treatment of advanced prostatitic cancer
41. Novel p21/WAF1/CIP1 mutations in superficial and invasive transcriptional cell carcinomas
42. Activation of cyclin D-dependent kinase 4 (cdk4) by mouse MO15associated kinase
43. Effects of imidazole derivatives on cytochrome p-450 from human hepatocytes in primary culture
44. Human weel kinase inhibits cell division by phosphorylating p34cdc2 exclusively on tyr15
45. The absence of p21/CIP1/WAF1 alters keratinocyte growth and differentiation
46. c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression
47. Ketoconazole: A thromboxane synthase and 5-lipoxygenase inhibitors with antimetastatic activity in B6-F10 melanoma
48. p27 modulates cell cycle progression and chemosensitivity in human malignant glioma
49. P53 derived from human tumor Cell lines and containing distinct point mutations can be activated to bind its consensus target sequence
50. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
51. Regulation of meiosis during mammalian spermatogenesis: The A-type cyclins and their associated cyclin-dependent kinases are differentially expressed in the germ-cell lineage
52. Cytotoxicity of ketoconazole in malignant cell lines
53. Efficacy of ketoconazole against Leishmania braziliensis
54. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxic model
55. High-intensity Raf signal causes cell cycle arrest mediated by p21/Cip1
56. Cancer cell cycles
57. Role of phosphorylation in p34cdc2 activation: Identification of activating kinase
58. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
59. Ketoconazole therapy in advanced prostatitic cancer
60. Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole
61. Ketoconazole: Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use
62. Ketoconazole therapy for women with acne and/or hirsutism
63. P27Kip1 overexpression causes apoptotic death of mammalian cells
64. Involvement of p27/Kip1 in G1 arrest mediated by an antiepidermal growth factor receptor monoclonal antibody